Woodbury Partners and its affiliates have many years and over a one hundred transactions of due diligence experience in the healthcare and information technology fields. Specifically, we can assist you in effectively completing your transactions from an operational, marketplace, customer, financial, scientific and IT perspective. Whether we are determining the satisfaction of a potential acquisitions customer base or the value and effectiveness of a software system our team is ready to help you avoid the pitfalls associated with all transactions. Carefully reviewing a firms billing or compliance practices may make the difference between a successful transaction or one that you have to go back to "explain" to your investors.
We can help you review operational work flow and through our relationship with Boston Medical and Scientific Advisors (BMSA), the validity of the science you are seeking to invest both your time and capital. Here are just a few examples of due diligence undertakings in which our team has participated:
- For a VC funded start-up we completed due diligence on a $10 million in Sales institutional
pharmacy including a review all operational ,financial and customer information.
- For a VC, performed marketing related due diligence on a start-up healthcare software firm.
- For a VC funded diagnostic laboratory company we peformed a complete review all data
associated with the acquisition of a $100 million in Sales clinical lab business.
- For a large publicly held clinical lab business we performed operational reviews of the research
and clinical labortories of several major teaching hospitals
- In preparation for acquisition we reviewed the financial, operations, customer, and billing
data of a twenty million dollar imaging company.
- To assist a hedge fund, with the aid of BMSA, we prepared a complete medical, scientific,
financial and marketing analysis of a new anti-viral drug that is expected to be a breakthrough
in the fight against AIDS. The report has since been sold to other institutional investors.
